Oct 6 (Reuters) – Knight Therapeutics Inc: * KNIGHT THERAPEUTICS – LAUNCHES TAVALISSE IN BRAZIL FOR CHRONIC IMMUNE THROMBOCYTOPENIA Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: ARCHIVE FOOTAGE OF JANNIK SINNER DURING PRACTICE SESSIONS RESENDING WITH COMPLETE SCRIPT SHOWS:…
ISTANBUL, Oct 6 (Reuters) - Journalism groups called on social media platform X on Tuesday…
By Medha Singh and Stella Qiu Oct 6 (Reuters) - World stocks scaled two-week highs…
By Maria Martinez BERLIN, Oct 6 (Reuters) - German industry — long the foundation of…
(Adds comments by president of Association of Property Developers of Madrid in paragraphs 9-10) MADRID,…
VIDEO SHOWS: ARCHIVE FOOTAGE OF JANNIK SINNER DURING PRACTICE SESSIONS RESENDING WITH COMPLETE SCRIPT SHOWS:…